<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(33)</volume><submitter>Lu H</submitter><funding>King Abdullah University of Science and Technology</funding><pubmed_abstract>Robust and ultrasensitive biosensing platforms for detecting clinically relevant biomarkers from liquid biopsies are vital for precision diagnostics. However, detecting low-abundance biomarkers such as microRNA typically necessitates complex and costly enzyme-based strategies like PCR or isothermal amplification. Here, a materials-driven approach is leveraged to rationally design stimuli-responsive, signal-amplifying, and graphically-encoded hydrogel microparticles, termed Novabeads, for enzyme-free and fluorescence-based biomarker detection. Novabeads incorporate pH-responsive acrylic acid moieties within a polyethylene glycol diacrylate-based network, enabling significant volume reduction (≈5 fold) upon pH modulation. This stimuli-responsive shrinking, coupled with high bioreceptor loading via thiol-ene click chemistry, enables rapid, enzyme-free optical signal amplification. As a proof-of-concept, fluorescently-labeled peptide nucleic acid (PNA) probes are designed for detecting the cancer biomarker miR-16, via a fluorogenic Förster resonance energy transfer (FRET)-based signal. Novabeads exhibit >30 fold signal enhancement over equivalent conventional hydrogel microparticles, driven by three synergistic mechanisms: increased probe loading (≈2.6 fold), enhanced target capture (≈2.8 fold), and shrinkage-driven amplification (≈5 fold), ultimately leading to over 7 fold reduction in detection limit (28.8 pM; 2.9 fmol), and an expanded linear dynamic range. This rationally designed materials-driven biosensing strategy enables next-generation robust, versatile and enzyme-free biosensors for liquid biopsy diagnostics.</pubmed_abstract><journal>Small (Weinheim an der Bergstrasse, Germany)</journal><pagination>e2503990</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12372440</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novabeads: Stimuli-Responsive Signal-Amplifying Hydrogel Microparticles for Enzymeless Fluorescence-Based Detection of microRNA Biomarkers.</pubmed_title><pmcid>PMC12372440</pmcid><pubmed_authors>Lu H</pubmed_authors><pubmed_authors>Hasan E</pubmed_authors><pubmed_authors>Alsulaiman D</pubmed_authors><pubmed_authors>Samman F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novabeads: Stimuli-Responsive Signal-Amplifying Hydrogel Microparticles for Enzymeless Fluorescence-Based Detection of microRNA Biomarkers.</name><description>Robust and ultrasensitive biosensing platforms for detecting clinically relevant biomarkers from liquid biopsies are vital for precision diagnostics. However, detecting low-abundance biomarkers such as microRNA typically necessitates complex and costly enzyme-based strategies like PCR or isothermal amplification. Here, a materials-driven approach is leveraged to rationally design stimuli-responsive, signal-amplifying, and graphically-encoded hydrogel microparticles, termed Novabeads, for enzyme-free and fluorescence-based biomarker detection. Novabeads incorporate pH-responsive acrylic acid moieties within a polyethylene glycol diacrylate-based network, enabling significant volume reduction (≈5 fold) upon pH modulation. This stimuli-responsive shrinking, coupled with high bioreceptor loading via thiol-ene click chemistry, enables rapid, enzyme-free optical signal amplification. As a proof-of-concept, fluorescently-labeled peptide nucleic acid (PNA) probes are designed for detecting the cancer biomarker miR-16, via a fluorogenic Förster resonance energy transfer (FRET)-based signal. Novabeads exhibit >30 fold signal enhancement over equivalent conventional hydrogel microparticles, driven by three synergistic mechanisms: increased probe loading (≈2.6 fold), enhanced target capture (≈2.8 fold), and shrinkage-driven amplification (≈5 fold), ultimately leading to over 7 fold reduction in detection limit (28.8 pM; 2.9 fmol), and an expanded linear dynamic range. This rationally designed materials-driven biosensing strategy enables next-generation robust, versatile and enzyme-free biosensors for liquid biopsy diagnostics.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-08T06:53:36.426Z</modification><creation>2026-04-07T23:31:28.183Z</creation></dates><accession>S-EPMC12372440</accession><cross_references><pubmed>40557570</pubmed><doi>10.1002/smll.202503990</doi></cross_references></HashMap>